Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections

Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy

(2015) P. Edwards et al.   PEDIATRICS

Evidence-based review of safety and efficacy in cerebral palsy

(2015) Ann Henderson Tilton   TOXICON

Questionnaire about the Adverse Events and Side Effects Following Botulinum Toxin A Treatment in Patients with Cerebral Palsy

(2015) Izabela Blaszczyk et al.   Toxins

Botulinum Toxin A for Nonambulatory Children with Cerebral Palsy: A Double Blind Randomized Controlled Trial

(2014) Lisa Copeland et al.   JOURNAL OF PEDIATRICS

Botulinum Toxin Type A in Children and Adolescents With Severe Cerebral Palsy

(2013) Ronit Mesterman et al.   JOURNAL OF CHILD NEUROLOGY

Safety of Botulinum Toxin A in Children and Adolescents with Cerebral Palsy in a Pragmatic Setting

(2013) Antigone Papavasiliou et al.   Toxins

Cerebral palsy: the whys and hows

(2012) Charlie Fairhurst   Archives of Disease in Childhood-Education and Practice Edition

Estimation of botulinum toxin type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy

(2012) Hristina Colovic et al.   BIOMEDICAL PAPERS-OLOMOUC

Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review

(2012) TAMIS W PIN et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Botulinum toxin: does the black box warning justify change in practice?

(2011) UNNI G NARAYANAN   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy

(2011) STEPHEN J O’FLAHERTY et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

What constitutes cerebral palsy?

(2010) Nadia Badawi et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Development and reliability of a system to classify gross motor function in children with cerebral palsy

(2010) Robert Palisano et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy

(2010) KRISHANT NAIDU et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement

(2010) S. C. Love et al.   EUROPEAN JOURNAL OF NEUROLOGY

Safety Considerations in the Use of Botulinum Toxins in Children With Cerebral Palsy

(2010) Susan D. Apkon et al.   PM&R

Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials

(2009) Cidronio Albavera-Hernández et al.   CLINICAL REHABILITATION

Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy

(2009) CLAIRE T LUNDY et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

FDA Requires Black Box Warnings on Labeling for Botulinum Toxin Products

(2009) Bridget M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comorbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level

(2009) M. I. Shevell et al.   NEUROLOGY